Ether

Ether

SCHEMBL9823903

CCOCC.F.[B]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL1361847 1.00
Ether SCHEMBL9750539 1.00 ALDH1A1 (0.41)
Ether SCHEMBL310584 0.95
Ether SCHEMBL811889 0.95 ALDH1A1 (0.44)
Ether SCHEMBL1345656 0.95
Ether SCHEMBL699018 0.95
Ether SCHEMBL11802524 0.90
Ether SCHEMBL421875 0.90
Ether SCHEMBL21326457 0.90
Ether SCHEMBL1133979 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112062728-A Synthetic method of 3, 5-dichloro-6-ethylpyrazine formamide 上海鑫凯化学科技有限公司 2020-12-11 CN claimed
CN-111760021-A Conjugate containing alpha-galactosylceramide analogue and saccharide antigen as well as preparation method and application thereof 广州中医药大学(广州中医药研究院) 2020-10-13 CN claimed
US-12612424-B2 HPK1 inhibitors and uses thereof REGOR PHARMACEUTICALS, INC. (US) 2026-04-28 US disclosed
US-12281101-B2 Bicyclic lactams and methods of use thereof GENENTECH, INC. (US) 2025-04-22 US disclosed
EP-3760625-B1 BICYCLIC LACTAMS AS RECEPTOR-INTERACTING PROTEIN-1 (RIP1) KINASE INHIBITORS FOR TREATING E.G. INFLAMMATORY DISEASES HOFFMANN LA ROCHE (CH) 2024-03-27 EP disclosed
US-11708344-B2 Flavone derivatives for the treatment and prophylaxis of hepatitis B virus disease HOFFMANN-LA ROCHE INC. (US) 2023-07-25 US disclosed
US-11667824-B2 Adhesive and its preparation and application COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2023-06-06 US disclosed
US-20230074887-A1 FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE HOFFMANN-LA ROCHE INC. (US) 2023-03-09 US disclosed
CN-115703796-A Preparation method of important intermediate of Reidesciclovir 苏州恩泰新材料科技有限公司 2023-02-17 CN disclosed
US-20220389037-A1 HPK1 INHIBITORS AND USES THEREOF REGOR PHARMACEUTICALS, INC. 2022-12-08 US disclosed
US-20220348559-A1 BICYCLIC LACTAMS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2022-11-03 US disclosed
WO-2014023258-A1 PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE F.HOFFMANN-LA ROCHE AG (CH) 2014-02-13 WO disclosed
EP-0194846-B1 PREPARATION OF THIENO-IMIDAZOLE DERIVATIVES PFIZER INC. (US) 1991-05-08 EP disclosed
US-4895679-A Process for production of chenodeoxycholic acid and novel intermediates useful for the process PRIME CHEMICALS TECHNOLOGY CORPORATION (US) 1990-01-23 US disclosed
US-4670564-A Preparation of thieno-imidazole derivatives PFIZER INC. (US) 1987-06-02 US disclosed
EP-0069810-B1 NOVEL DIBENZOXEPINS, THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND THE USE OF DIBENZOXEPINS IN THE TREATMENT OF ALLERGIC CONDITIONS MERCK & CO. INC. (US) 1986-12-03 EP disclosed
EP-0194846-A2 Preparation of thieno-imidazole derivatives PFIZER INC. (US) 1986-09-17 EP disclosed
EP-0069810-A1 Novel dibenzoxepins, their preparation, compositions containing them and the use of dibenzoxepins in the treatment of allergic conditions MERCK & CO. INC. (US) 1983-01-19 EP disclosed
US-4282365-A Dibenz[b,e]oxepin compounds MERCK & CO., INC. (US) 1981-08-04 US disclosed
US-3966755-A OPTICAL BRIGHTENERS CIBA-GEIGY CORPORATION (US) 1976-06-29 US disclosed